Details of the Drug

General Information of Drug (ID: DM19A89)

Drug Name
Androgen
Indication
Disease Entry ICD 11 Status REF
Hypogonadism, male N.A. Investigative [1]
Prostate cancer 2C82.0 Investigative [2]
Affected Organisms
Humans and other mammals
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C22H32O3
Canonical SMILES
CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C
InChI
1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1
InChIKey
PDMMFKSKQVNJMI-BLQWBTBKSA-N
Cross-matching ID
PubChem CID
5995
ChEBI ID
CHEBI:9466
CAS Number
57-85-2
UNII
WI93Z9138A
DrugBank ID
DB01420
TTD ID
D0SP7S
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications. Curr Pharm Des. 2017;23(30):4475-4483.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.